Popular Design for Oyster Extract Powder - Cytisine – Chenlv Detail:
CAS No.: 485-35 -8
Latin name: genera Laburnum, Cytisus
Part used: whole herb
Appearance: off-white to yellowish-brown crystalline solid
Test method: HPLC
Specification: 98%
Cytisine is an alkaloid naturally derived from the Fabaceae family of plants including the genera Laburnum and Cytisus. Recent studies have shown it to be a more effective and significantly more affordable smoking cessation treatment than nicotine replacement therapy. Also known as baptitoxine or sophorine, cytisine has been used as a smoking cessation treatment since 1964, and is relatively unknown in regions outside of central and Eastern Europe. Cytisine is a partial nicotinic acetylcholine agonist with a half-life of 4.8 hours. Recent Phase III clinical trials using Tabex (a brand of Cytisine marketed by Sopharma AD) have shown similar efficacy to varenicline, but at a fraction of the cost.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
To continuously increase the administration process by virtue of the rule of "sincerely, good religion and excellent are the base of company development", we commonly absorb the essence of linked goods internationally, and continually build new solutions to fulfill the requires of shoppers for Popular Design for Oyster Extract Powder - Cytisine – Chenlv, The product will supply to all over the world, such as: Saudi Arabia , Estonia , Brasilia , In order to meet more market demands and long-term development, a 150, 000-square-meter new factory is under construction, which will be put into use in 2014. Then, we shall own a large capacity of producing. Of course, we will continue improving the service system to meet the requirements of customers, bringing health, happiness and beauty to everyone.
By Matthew
from Rotterdam
- 2018.06.12 16:22
The factory technical staff gave us a lot of good advice in the cooperation process, this is very good, we are very grateful.
By Ingrid
from Poland
- 2017.04.08 14:55